Literature DB >> 10214912

Involvement of poly(ADP-ribose) polymerase in base excision repair.

F Dantzer1, V Schreiber, C Niedergang, C Trucco, E Flatter, G De La Rubia, J Oliver, V Rolli, J Ménissier-de Murcia, G de Murcia.   

Abstract

Poly(ADP-ribose) polymerase (PARP) is a zinc-finger DNA binding protein that detects and signals DNA strand breaks generated directly or indirectly by genotoxic agents. In response to these lesions, the immediate poly(ADP-ribosylation) of nuclear proteins converts DNA interruptions into intracellular signals that activate DNA repair or cell death programs. To elucidate the biological function of PARP in vivo, the mouse PARP gene was inactivated by homologous recombination to generate mice lacking a functional PARP gene. PARP knockout mice and the derived mouse embryonic fibroblasts (MEFs) were acutely sensitive to monofunctional alkylating agents and gamma-irradiation demonstrating that PARP is involved in recovery from DNA damage that triggers the base excision repair (BER) process. To address the issue of the role of PARP in BER, the ability of PARP-deficient mammalian cell extracts to repair a single abasic site present on a circular duplex plasmid molecule was tested in a standard in vitro repair assay. The results clearly demonstrate, for the first time, the involvement of PARP in the DNA synthesis step of the base excision repair process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214912     DOI: 10.1016/s0300-9084(99)80040-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  93 in total

Review 1.  Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.

Authors:  F J Oliver; J Menissier-de Murcia; G de Murcia
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  Sensing DNA damage by PARP-like fingers.

Authors:  Stefania Petrucco
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

3.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

Review 4.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

Review 5.  Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency.

Authors:  Julie K Horton; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2006-11-20

6.  PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres.

Authors:  Marla Gomez; Jun Wu; Valérie Schreiber; John Dunlap; Françoise Dantzer; Yisong Wang; Yie Liu
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

Review 7.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

8.  Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.

Authors:  Sumin Han; J Chad Brenner; Aaron Sabolch; Will Jackson; Corey Speers; Kari Wilder-Romans; Karen E Knudsen; Theodore S Lawrence; Arul M Chinnaiyan; Felix Y Feng
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

9.  Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.

Authors:  Robert L Dilley; Weijie Poh; Douglas E Gladstone; James G Herman; Margaret M Showel; Judith E Karp; Michael A McDevitt; Keith W Pratz
Journal:  Leuk Res       Date:  2013-12-30       Impact factor: 3.156

10.  Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.

Authors:  Richard Wiegand; Jianmei Wu; Xianyi Sha; Patricia LoRusso; Jing Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-11-27       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.